View in EDS PDF Full Text

Meningococcal meningitis in Spain in the Horizon 2030: A position paper.

Saved in:
Bibliographic Details
Title: Meningococcal meningitis in Spain in the Horizon 2030: A position paper.
Alternate Title: La meningitis meningocócica en España en el Horizonte 2030: Un documento de opinión.
Authors: Moraga-Llop, Fernando1, Andradas, Elena2, Blesa-Baviera, Luis Carlos3, Cantón, Rafael4, González del Castillo, Juan5, Martinón-Torres, Federico6, Moya, Elena7, Trilla, Antoni8, Vazquez, Julio9, Villena, Rodolfo Javier10, Ruiz-Galiana, Julián11, De Lucas Ramos, Pilar12, García-Botella, Alejandra13, García-Lledó, Alberto14, Hernández-Sampelayo, Teresa15, Gómez-Pavón, Javier16, Martín-Delgado, Mari Cruz17, Martín Sánchez, Francisco Javier5, Martínez-Sellés, Manuel18, Molero García, José María19
Source: Revista Española de Quimioterapia. ago2024, Vol. 37 Issue 4, p285-298. 14p.
Subjects: MENINGOCOCCAL infections, NEISSERIA meningitidis, MENINGITIS, VACCINES, EPIDEMICS, ANTI-infective agents, CHEMOPREVENTION
Geographic Terms: SPAIN
Abstract (English): Meningococcal meningitis (MM) and invasive meningococcal disease remain a major public health problem that generates enormous public alarm. It is caused by Neisseria meningitidis, a Gram-negative diplococcus with an enormous capacity for acute and rapidly progressive disease, both episodic and epidemic in nature, with early diagnosis and treatment playing a major role. It occurs at any age, but is most common in children under 5 years of age followed by adolescents. Although most cases occur in healthy people, the incidence is higher in certain risk groups. Despite advances in reducing the incidence, it is estimated that in 2017 there were around 5 million new cases of MM worldwide, causing approximately 290,000 deaths and a cumulative loss of about 20,000,000 years of healthy life. In Spain, in the 2021/22 season, 108 microbiologically confirmed cases of MM were reported, corresponding to an incidence rate of 0.23 cases per 100,000 inhabitants. This is a curable and, above all, vaccine-preventable disease, for which the World Health Organisation has drawn up a roadmap with the aim of reducing mortality and sequelae by 2030. For all these reasons, the Illustrious Official College of Physicians of Madrid (ICOMEM) and the Medical Associations of 8 other provinces of Spain, have prepared this opinion document on the situation of MM in Spain and the resources and preparation for the fight against it in our country. The COVID-19 and Emerging Pathogens Committee of ICOMEM has invited experts in the field to participate in the elaboration of this document. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): La meningitis meningocócica (MM) y la enfermedad me ningocócica invasiva siguen siendo un importante problema de salud pública que genera una enorme alarma social. Está causada por Neisseria meningitidis, un diplococo Gram negativo con una enorme capacidad para producir una enfermedad aguda y de rápida evolución, tanto de carácter episódico como epidémico, en cuya evolución influyen enormemente el diagnóstico y el tratamiento precoces. Se presenta a cualquier edad, pero es más frecuente en niños menores de 5 años seguido de los adolescentes. Aunque el mayor número de casos se da en personas sanas, la incidencia es superior en determinados grupos de riesgo. A pesar de los avances en la reducción de la incidencia, se estima que en 2017 se produjeron alrededor de 5 millones de nuevos casos de MM en todo el mundo causando aproximadamente 290.000 muertes y una pérdida de unos 20.000.000 de años de vida sana acumulada. En España, en la temporada 2021/22, se notificaron 108 casos de MM con confirmación microbiológica, lo que corresponde a una tasa de incidencia de 0,23 casos por 100.000 habitantes. Se trata de una enfermedad curable y, sobre todo, prevenible con vacunas, para la que la Organización Mundial de la Salud ha elaborado una hoja de ruta con el objetivo de reducir su mortalidad y secuelas en 2030. Por todo ello, el Ilustre Colegio Oficial de Médicos de Madrid (ICOMEM) y los Colegios de Médicos de otras 8 provincias de España, han elaborado este documento de opinión sobre la situación del MM en España y los recursos y preparación para la lucha contra el mismo en nuestro país. El Comité de COVID-19 y Patógenos Emergentes del ICOMEM ha invitado a expertos en la materia a participar en la elaboración de este documento. [ABSTRACT FROM AUTHOR]
Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 178331535
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Meningococcal meningitis in Spain in the Horizon 2030: A position paper.
– Name: TitleAlt
  Label: Alternate Title
  Group: TiAlt
  Data: La meningitis meningocócica en España en el Horizonte 2030: Un documento de opinión.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Moraga-Llop%2C+Fernando%22">Moraga-Llop, Fernando</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Andradas%2C+Elena%22">Andradas, Elena</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Blesa-Baviera%2C+Luis+Carlos%22">Blesa-Baviera, Luis Carlos</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Cantón%2C+Rafael%22">Cantón, Rafael</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22González+del+Castillo%2C+Juan%22">González del Castillo, Juan</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Martinón-Torres%2C+Federico%22">Martinón-Torres, Federico</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Moya%2C+Elena%22">Moya, Elena</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Trilla%2C+Antoni%22">Trilla, Antoni</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Vazquez%2C+Julio%22">Vazquez, Julio</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Villena%2C+Rodolfo+Javier%22">Villena, Rodolfo Javier</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Ruiz-Galiana%2C+Julián%22">Ruiz-Galiana, Julián</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22De+Lucas+Ramos%2C+Pilar%22">De Lucas Ramos, Pilar</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22García-Botella%2C+Alejandra%22">García-Botella, Alejandra</searchLink><relatesTo>13</relatesTo><br /><searchLink fieldCode="AR" term="%22García-Lledó%2C+Alberto%22">García-Lledó, Alberto</searchLink><relatesTo>14</relatesTo><br /><searchLink fieldCode="AR" term="%22Hernández-Sampelayo%2C+Teresa%22">Hernández-Sampelayo, Teresa</searchLink><relatesTo>15</relatesTo><br /><searchLink fieldCode="AR" term="%22Gómez-Pavón%2C+Javier%22">Gómez-Pavón, Javier</searchLink><relatesTo>16</relatesTo><br /><searchLink fieldCode="AR" term="%22Martín-Delgado%2C+Mari+Cruz%22">Martín-Delgado, Mari Cruz</searchLink><relatesTo>17</relatesTo><br /><searchLink fieldCode="AR" term="%22Martín+Sánchez%2C+Francisco+Javier%22">Martín Sánchez, Francisco Javier</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Martínez-Sellés%2C+Manuel%22">Martínez-Sellés, Manuel</searchLink><relatesTo>18</relatesTo><br /><searchLink fieldCode="AR" term="%22Molero+García%2C+José+María%22">Molero García, José María</searchLink><relatesTo>19</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Revista+Española+de+Quimioterapia%22">Revista Española de Quimioterapia</searchLink>. ago2024, Vol. 37 Issue 4, p285-298. 14p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22MENINGOCOCCAL+infections%22">MENINGOCOCCAL infections</searchLink><br /><searchLink fieldCode="DE" term="%22NEISSERIA+meningitidis%22">NEISSERIA meningitidis</searchLink><br /><searchLink fieldCode="DE" term="%22MENINGITIS%22">MENINGITIS</searchLink><br /><searchLink fieldCode="DE" term="%22VACCINES%22">VACCINES</searchLink><br /><searchLink fieldCode="DE" term="%22EPIDEMICS%22">EPIDEMICS</searchLink><br /><searchLink fieldCode="DE" term="%22ANTI-infective+agents%22">ANTI-infective agents</searchLink><br /><searchLink fieldCode="DE" term="%22CHEMOPREVENTION%22">CHEMOPREVENTION</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22SPAIN%22">SPAIN</searchLink>
– Name: Abstract
  Label: Abstract (English)
  Group: Ab
  Data: Meningococcal meningitis (MM) and invasive meningococcal disease remain a major public health problem that generates enormous public alarm. It is caused by Neisseria meningitidis, a Gram-negative diplococcus with an enormous capacity for acute and rapidly progressive disease, both episodic and epidemic in nature, with early diagnosis and treatment playing a major role. It occurs at any age, but is most common in children under 5 years of age followed by adolescents. Although most cases occur in healthy people, the incidence is higher in certain risk groups. Despite advances in reducing the incidence, it is estimated that in 2017 there were around 5 million new cases of MM worldwide, causing approximately 290,000 deaths and a cumulative loss of about 20,000,000 years of healthy life. In Spain, in the 2021/22 season, 108 microbiologically confirmed cases of MM were reported, corresponding to an incidence rate of 0.23 cases per 100,000 inhabitants. This is a curable and, above all, vaccine-preventable disease, for which the World Health Organisation has drawn up a roadmap with the aim of reducing mortality and sequelae by 2030. For all these reasons, the Illustrious Official College of Physicians of Madrid (ICOMEM) and the Medical Associations of 8 other provinces of Spain, have prepared this opinion document on the situation of MM in Spain and the resources and preparation for the fight against it in our country. The COVID-19 and Emerging Pathogens Committee of ICOMEM has invited experts in the field to participate in the elaboration of this document. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label: Abstract (Spanish)
  Group: Ab
  Data: La meningitis meningocócica (MM) y la enfermedad me ningocócica invasiva siguen siendo un importante problema de salud pública que genera una enorme alarma social. Está causada por Neisseria meningitidis, un diplococo Gram negativo con una enorme capacidad para producir una enfermedad aguda y de rápida evolución, tanto de carácter episódico como epidémico, en cuya evolución influyen enormemente el diagnóstico y el tratamiento precoces. Se presenta a cualquier edad, pero es más frecuente en niños menores de 5 años seguido de los adolescentes. Aunque el mayor número de casos se da en personas sanas, la incidencia es superior en determinados grupos de riesgo. A pesar de los avances en la reducción de la incidencia, se estima que en 2017 se produjeron alrededor de 5 millones de nuevos casos de MM en todo el mundo causando aproximadamente 290.000 muertes y una pérdida de unos 20.000.000 de años de vida sana acumulada. En España, en la temporada 2021/22, se notificaron 108 casos de MM con confirmación microbiológica, lo que corresponde a una tasa de incidencia de 0,23 casos por 100.000 habitantes. Se trata de una enfermedad curable y, sobre todo, prevenible con vacunas, para la que la Organización Mundial de la Salud ha elaborado una hoja de ruta con el objetivo de reducir su mortalidad y secuelas en 2030. Por todo ello, el Ilustre Colegio Oficial de Médicos de Madrid (ICOMEM) y los Colegios de Médicos de otras 8 provincias de España, han elaborado este documento de opinión sobre la situación del MM en España y los recursos y preparación para la lucha contra el mismo en nuestro país. El Comité de COVID-19 y Patógenos Emergentes del ICOMEM ha invitado a expertos en la materia a participar en la elaboración de este documento. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=178331535
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.37201/req/023.2024
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 14
        StartPage: 285
    Subjects:
      – SubjectFull: MENINGOCOCCAL infections
        Type: general
      – SubjectFull: NEISSERIA meningitidis
        Type: general
      – SubjectFull: MENINGITIS
        Type: general
      – SubjectFull: VACCINES
        Type: general
      – SubjectFull: EPIDEMICS
        Type: general
      – SubjectFull: ANTI-infective agents
        Type: general
      – SubjectFull: CHEMOPREVENTION
        Type: general
      – SubjectFull: SPAIN
        Type: general
    Titles:
      – TitleFull: Meningococcal meningitis in Spain in the Horizon 2030: A position paper.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Moraga-Llop, Fernando
      – PersonEntity:
          Name:
            NameFull: Andradas, Elena
      – PersonEntity:
          Name:
            NameFull: Blesa-Baviera, Luis Carlos
      – PersonEntity:
          Name:
            NameFull: Cantón, Rafael
      – PersonEntity:
          Name:
            NameFull: González del Castillo, Juan
      – PersonEntity:
          Name:
            NameFull: Martinón-Torres, Federico
      – PersonEntity:
          Name:
            NameFull: Moya, Elena
      – PersonEntity:
          Name:
            NameFull: Trilla, Antoni
      – PersonEntity:
          Name:
            NameFull: Vazquez, Julio
      – PersonEntity:
          Name:
            NameFull: Villena, Rodolfo Javier
      – PersonEntity:
          Name:
            NameFull: Ruiz-Galiana, Julián
      – PersonEntity:
          Name:
            NameFull: De Lucas Ramos, Pilar
      – PersonEntity:
          Name:
            NameFull: García-Botella, Alejandra
      – PersonEntity:
          Name:
            NameFull: García-Lledó, Alberto
      – PersonEntity:
          Name:
            NameFull: Hernández-Sampelayo, Teresa
      – PersonEntity:
          Name:
            NameFull: Gómez-Pavón, Javier
      – PersonEntity:
          Name:
            NameFull: Martín-Delgado, Mari Cruz
      – PersonEntity:
          Name:
            NameFull: Martín Sánchez, Francisco Javier
      – PersonEntity:
          Name:
            NameFull: Martínez-Sellés, Manuel
      – PersonEntity:
          Name:
            NameFull: Molero García, José María
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: ago2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 02143429
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Revista Española de Quimioterapia
              Type: main
ResultId 1